The International Journal of Pharmaceutics publishes innovative papers, reviews, mini-reviews, rapid communications and notes
dealing with physical, chemical, biological, microbiological and engineering studies related to the conception, design, production, characterisation
and evaluation of drug delivery systems in vitro and in vivo. "Drug" is defined ... click here for full Aims & Scope
The International Journal of Pharmaceutics publishes innovative papers, reviews, mini-reviews, rapid communications and notes
dealing with physical, chemical, biological, microbiological and engineering studies related to the conception, design, production, characterisation
and evaluation of drug delivery systems in vitro and in vivo. "Drug" is defined as any therapeutic or diagnostic entity,
including oligonucleotides, gene constructs and radiopharmaceuticals.
Areas of particular interest include: physical pharmacy;
polymer chemistry and physical chemistry as applied to pharmaceutics; excipient function and characterisation; biopharmaceutics; absorption
mechanisms; membrane function and transport; novel routes and modes of delivery; responsive delivery systems, feedback and control mechanisms
including biosensors; applications of cell and molecular biology to drug delivery; prodrug design; bioadhesion (carrier-ligand interactions);
and biotechnology (protein and peptide formulation and delivery).
Editorial Policy
The over-riding criteria for publication
are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental
detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make
alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption
that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly
or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not
be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.
Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach
taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose
fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work
which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not
be published unless it provides new insight into fundamental principles.
Hide Aims & Scope
Editor-in-Chief: Contact the Editor
A.T. Florence
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company